State Of Wyoming Prelude Therapeutics Inc Transaction History

State Of Wyoming

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 13, 2022	SELL	$6.9 - $13.22 $3,753 - $7,191	-544 Closed	0 $0
Q4 2021 Feb 11, 2022	SELL	$11.89 - $31.74 $344 - $920	-29 Reduced 5.06%	544 $7,000
Q3 2021 Feb 11, 2022	SELL	$25.78 - $38.65 $7,115 - $10,667	-276 Reduced 32.51%	573 $18,000
Q2 2021 Feb 11, 2022	BUY	$28.63 - $44.3 $12,883 - $19,935	450 Added 112.78%	849 $24,000
Q1 2021 Feb 08, 2022	BUY	$39.27 - $91.68 $15,668 - $36,580	399 New	399 $17,000

35.7M

500

300

Ticker PRLD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 36,369,200
Market Cap $34.6M
Description
Prelude Therapeutics Incorporated, a clinical-stage precision oncology company, focuses on the discovery and development of novel precision cancer medicines to underserved patients. It is developing PRT543 that is in Phase 1 clinical trials in select solid tumors and myeloid malignancies; and PRT811, which is in Phase 1 clinical trials in solid ...

Get notified when there are updates to the investment portfolio of State Of Wyoming, based on Form 13F filings with the SEC.

Stay updated on State Of Wyoming with notifications on news.